Recent Updates
Recently added Catalysts
RMD Positive Sentiment

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Key Takeaway: Resmed has announced that it will release its third quarter fiscal 2025 earnings on April 23, 2025, after market hours. A webcast will follow the announcement, where management will discuss the results and additional material information. The company emphasizes its dedication to improving health technologies and aims to provide accessible and effective healthcare solutions globally.
Price reaction · baseline $222.3 (2025-04-01 close) · hit after-hours · 1 other RMD headline(s) in the window, move may be shared
day 0 close
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Resmed plans to report its financial and operational results, highlighting the company's ongoing growth and performance.
  • The management will host a webcast to discuss results, showing transparency and engagement with stakeholders.
  • Resmed's commitment to pioneering innovative health technologies indicates a strong future focus.

Full Press Release Details

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: https://investor.resmed.com
Date: Wednesday, April 23, 2025
Time: 1:30 p.m. PDT / 4:30 p.m. EDT
International: London, Wednesday, April 23, 2025, 9:30 p.m. BST
Sydney, Thursday, April 24, 2025, 6:30 a.m. AEST
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 23, 2025, until May 7, 2025, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13752711
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@Resmed.com news@Resmed.com

Frequently Asked Questions

When will Resmed announce Q3 fiscal year 2025 results?

Resmed will announce Q3 fiscal year 2025 results on April 23, 2025.

How can I access the earnings webcast?

The earnings webcast can be accessed at https://investor.resmed.com.

What time is the earnings call scheduled?

The earnings call is scheduled for 1:30 p.m. PDT on April 23, 2025.

Will there be a replay of the earnings webcast?

Yes, a replay will be available two hours after the webcast on Resmed's website.

What is the conference ID for the phone replay?

The conference ID for the phone replay is 13752711.

Last updated: Apr 2, 2025